Explore the Concept of Platform Methods in mRNA Quality Control & the Need for Maintaining Validation Status in a Quality Control Environment

Time: 2:00 pm
day: Conference Day Two


  • Discuss the verification process for platform methods and the regulatory perspective on the extent of verification required for new molecules
  • What are the innovative platforms for mRNA therapeutic development, focusing on adherence to regulatory guidance
  • Examine challenges in maintaining consistency across platforms and addressing varying regulatory expectations